Life Insurance With Congestive Heart Failure: 2027 Underwriting Guide
Life insurance with congestive heart failure (CHF) can be difficult—but it is not always impossible. The underwriting outcome depends heavily on the cause of the heart failure, ejection fraction (EF), whether heart function has recovered, symptoms, hospitalizations, medications, arrhythmias, valve disease, coronary artery disease, and how stable the condition is today.
Can You Get Life Insurance With Congestive Heart Failure?
Yes, in selected cases. Active or significant CHF is often a decline for traditional life insurance, but recovered or mild cases can sometimes be considered when heart function has improved, the underlying cause is favorable, symptoms are controlled, and recent testing is reassuring. An EF above 50% can strengthen a case, but EF alone does not guarantee approval.
Before applying, review the EF, cause, most recent echocardiogram, hospitalizations, medications, rhythm history, and current symptoms.
Table of Contents
- What CHF Means
- How CHF Is Underwritten
- PinnacleQuote CHF Screening Guide
- Ejection Fraction
- Why the Cause Matters
- Recovered Heart Failure
- Tests Underwriters Review
- Hospitalizations & Symptoms
- Medications
- Arrhythmias, Pacemakers & ICDs
- CAD & Valve Disease
- Term & GUL Options
- Final Expense Options
- If You Were Declined
- People Also Ask
- FAQ
What Is Congestive Heart Failure?
Heart failure means the heart is not pumping or filling well enough to meet the body’s needs. “Congestive” heart failure often refers to heart failure accompanied by fluid buildup, which can cause shortness of breath, swelling, fatigue, weight gain from fluid, or difficulty lying flat.
Heart failure is not one single condition. It can occur with a reduced ejection fraction, mildly reduced EF, or even a preserved EF. That distinction matters medically and for life insurance underwriting.
How Do Life Insurance Companies Underwrite CHF?
CHF is a high-risk cardiac impairment, so underwriters usually look beyond the diagnosis and focus on the current prognosis.
Heart function
Current EF, prior EF, ventricular size, wall motion, and whether function has improved.
Clinical stability
Symptoms, NYHA functional class, recent hospitalizations, fluid retention, exercise tolerance, and current treatment.
Underlying cause
Cardiomyopathy, coronary artery disease, prior heart attack, valve disease, arrhythmia, hypertension, alcohol-related disease, or another cause.
Current carrier underwriting guidance also shows how conservatively insurers can treat significant cardiomyopathy and related heart-failure histories. Some cardiomyopathy cases require substantial stability before consideration, and moderate or severe disease may be declined.
PinnacleQuote CHF Underwriting Screening Guide
The following is our universal screening framework for organizing CHF cases before carrier-specific review. It is not a carrier guarantee or an approval promise.
| Profile | Initial Screening Direction | What Could Improve the Case |
|---|---|---|
| Active / significant CHF | Likely decline for traditional coverage | Long-term stability, no recent hospitalization, improved function, favorable cause, reassuring testing |
| EF above 50% | Possible consideration in selected cases | Normal or near-normal function, minimal symptoms, strong functional capacity, stable treatment, no major complications |
| Recovered left-sided heart failure | Screen similarly to the underlying dilated cardiomyopathy history when appropriate | Documented recovery, stable EF, favorable imaging, no recurrent decompensation |
| CHF secondary to another cardiac disease | Rate for the cause as well as the heart-failure history | Successful treatment of the cause, no residual ischemia, rhythm control, stable valves, good exercise capacity |
Why Ejection Fraction Matters in Life Insurance Underwriting
Ejection fraction (EF) measures the percentage of blood pumped out of the left ventricle with each contraction.
| EF Range | Clinical Category | Underwriting Meaning |
|---|---|---|
| ≤40% | Heart failure with reduced EF (HFrEF) | Usually a major underwriting concern, especially if persistent or symptomatic. |
| 41%–49% | Heart failure with mildly reduced EF (HFmrEF) | Still abnormal; outcome depends on cause, symptoms, trajectory, and current testing. |
| ≥50% | May fit heart failure with preserved EF (HFpEF) when other diagnostic criteria are present | More favorable than markedly reduced EF in many cases, but not automatically “normal underwriting.” |
| Improved EF | Prior EF ≤40% with follow-up EF >40% | Recovery trend matters, but prior heart failure remains part of the underwriting history. |
The American Heart Association notes that normal EF is generally around 55%–70%, while EF of 41%–49% is mildly reduced and EF under 40% usually indicates heart failure or cardiomyopathy.
Why the Cause of CHF Matters
Underwriters want to know why the heart failed. The diagnosis “CHF” alone is not enough.
Common causes or associated conditions include:
- Coronary artery disease or prior myocardial infarction
- Dilated cardiomyopathy
- Long-standing hypertension
- Valve disease
- Atrial fibrillation or other arrhythmias
- Alcohol-related cardiomyopathy
- Viral or inflammatory cardiomyopathy
- Peripartum cardiomyopathy
- Congenital or structural heart disease
A case in which the underlying cause has been corrected and heart function has recovered can be viewed very differently from ongoing progressive cardiomyopathy.
Can Recovered Heart Failure Qualify for Life Insurance?
Possibly. Recovery is one of the most important positive factors in a CHF case.
Helpful evidence can include:
- Improved EF over time
- No recent hospitalizations or emergency visits
- Stable medication regimen
- No active fluid overload
- Good exercise tolerance
- Stable rhythm
- No active ischemia
- Favorable echocardiogram or stress-test findings
When the left ventricle has recovered after a cardiomyopathy-type event, underwriting may focus heavily on the original cause, the duration of recovery, and whether there has been recurrence.
What Cardiac Tests Do Underwriters Review?
A CHF application may involve a detailed review of recent cardiac testing.
- Echocardiogram: EF, chamber size, valve function, wall motion, pulmonary pressures
- Stress test: exercise capacity, ischemia, symptoms, blood-pressure response
- Cardiac catheterization / coronary angiography: coronary anatomy when CAD is involved
- ECG / Holter / event monitor: rhythm and arrhythmia burden
- BNP or NT-proBNP: can support heart-failure assessment and may help show ongoing cardiac stress
- Cardiac MRI: may clarify cardiomyopathy, scar, inflammation, or structure
The ACC/AHA/HFSA framework also recognizes BNP/NT-proBNP and filling-pressure evidence as important in diagnosing forms of heart failure when EF is not clearly reduced.
How Do Hospitalizations and Symptoms Affect Life Insurance?
Recent CHF hospitalization is one of the strongest negative underwriting signals because it suggests recent decompensation.
Underwriters may ask about:
- Last hospitalization date
- Number of CHF admissions
- Shortness of breath at rest or exertion
- Orthopnea or inability to lie flat
- Edema or fluid retention
- Weight fluctuations from fluid
- Exercise tolerance
- Need for oxygen
Longer periods without hospitalization, stable weight, minimal symptoms, and improved exercise capacity can strengthen the overall presentation.
Do Heart Failure Medications Affect Life Insurance?
The medication list helps the underwriter understand both severity and stability. Modern guideline-directed heart-failure therapy can include several drug classes, and being on appropriate treatment is not automatically negative.
What matters is whether the applicant is stable on therapy, tolerating it, and showing favorable objective results.
How Do Atrial Fibrillation, Pacemakers, or ICDs Affect CHF Underwriting?
Arrhythmias can add risk depending on type, burden, treatment, and heart function.
Atrial fibrillation is common in heart-failure populations and may be acceptable in selected cases when well controlled. Pacemaker history is evaluated based on the reason for implantation and the underlying heart condition.
An implantable cardioverter-defibrillator (ICD) usually signals a more serious arrhythmic or cardiomyopathy history and can materially limit traditional life-insurance options. Current Banner underwriting guidance lists an automatic implantable cardioverter-defibrillator among declined situations.
What If CHF Is Caused by CAD or Valve Disease?
If heart failure resulted from coronary artery disease, prior heart attack, stent, bypass surgery, or valve disease, the insurer will underwrite both the heart-failure history and the underlying cardiac disease.
For CAD, important factors include:
- Number and severity of affected vessels
- Prior heart attack
- Stent or bypass history
- Residual ischemia
- EF and wall motion
- Stress-test performance
For valve disease, the underwriter may review valve severity, repair or replacement, residual regurgitation/stenosis, pulmonary pressures, and ventricular function.
Related guides: life insurance with heart disease, life insurance after a heart attack, and life insurance with atrial fibrillation.
Can You Get Term Life or GUL With CHF?
Possibly, but traditional term and GUL underwriting will usually require a favorable recovered or mild-risk profile. Active CHF, low EF, recent hospitalization, significant symptoms, or advanced cardiomyopathy can result in postponement or decline.
When traditional coverage is possible, the best carrier is often determined by the cause of CHF and the current cardiac profile rather than by price alone.
See our GUL guide and high-risk life insurance guide.
What If Traditional Life Insurance Is Not Available?
Final expense or guaranteed-issue coverage can be a fallback, but it should not automatically be the first recommendation for every applicant with CHF.
If the condition has recovered or stabilized, it is worth screening traditional term, GUL, simplified-issue, and final-expense options before defaulting to guaranteed issue.
Guaranteed-issue policies typically have lower face amounts and may include a graded death-benefit period for non-accidental death. Product terms vary by carrier and state.
What If You Were Declined for Life Insurance Because of CHF?
A decline is not always the end of the process. First determine exactly why the carrier declined the case.
- Confirm the current EF and prior EF.
- Identify the cause of the heart failure.
- Check the date of the last hospitalization or decompensation.
- Review the newest echocardiogram, stress test, catheterization, rhythm monitoring, and cardiology notes.
- Document whether heart function has recovered.
- Use informal underwriting before submitting another formal application.
CHF underwriting is too case-specific to guess from a diagnosis alone.
People Also Ask About CHF and Life Insurance
Is congestive heart failure an automatic life insurance decline?
No, but active or significant CHF is commonly difficult to insure traditionally. Recovered or mild cases may be considered depending on EF, cause, stability, symptoms, testing, and hospitalization history.
Can you get life insurance with an EF over 50%?
Possibly. EF above 50% can strengthen a case, but preserved EF does not rule out heart failure. Underwriters still evaluate symptoms, filling pressures, cause, hospitalizations, medications, and other cardiac findings.
What EF is considered reduced?
Current heart-failure classifications generally define reduced EF as 40% or less, mildly reduced EF as 41%–49%, and preserved EF as 50% or higher when other diagnostic criteria for heart failure are present.
Can recovered cardiomyopathy qualify for life insurance?
Yes, selected recovered cardiomyopathy cases can sometimes qualify. Underwriters look closely at the cause, how long recovery has been maintained, the current EF, symptoms, rhythm, and whether there have been recurrent events.
Does a pacemaker mean you cannot get life insurance?
Not automatically. The reason for the pacemaker, underlying heart disease, EF, rhythm history, and current stability are more important than the device alone.
Does an ICD affect life insurance approval?
Yes. An implanted defibrillator often reflects a higher-risk cardiomyopathy or arrhythmia history and can significantly restrict traditional life-insurance options.
Congestive Heart Failure Life Insurance FAQ
What records are most useful for CHF underwriting?
Recent cardiology notes, echocardiograms, stress testing, catheterization reports when applicable, hospital discharge summaries, rhythm-monitoring results, medication lists, and recent labs can all help establish current stability.
Does BNP or NT-proBNP matter?
It can. Natriuretic peptides are used clinically in heart-failure assessment and may help show ongoing cardiac stress. Underwriters interpret them together with symptoms, EF, imaging, renal function, and the overall clinical picture.
Can lifestyle changes alone improve my life insurance rating?
Underwriters focus on objective medical evidence. Lifestyle changes can support better health, but improved testing, stability, treatment adherence, and time since the last event are what establish the underwriting picture.
Should I apply immediately after a CHF hospitalization?
Usually not without first screening the case. Recent decompensation often leads to postponement or decline, and a period of stability may materially change the outcome.
Who makes the final underwriting decision?
The issuing insurer determines eligibility, rate class, product availability, and premium. PinnacleQuote can help organize the medical history and compare underwriting before a formal application.
Bottom Line: CHF Underwriting Is About Recovery, Cause, and Current Function
Congestive heart failure is one of the more difficult cardiac impairments in life insurance underwriting, but the diagnosis alone does not tell the full story.
The strongest cases usually show a favorable cause, improved or preserved heart function, no recent hospitalization, minimal symptoms, stable treatment, and reassuring cardiac testing.
With CHF, the right question is not simply “Do you have heart failure?” It is “What caused it, how well has the heart recovered, and what does the current objective testing show?”
Final eligibility and pricing are determined by the issuing insurer.
Sources & Review Method
Reviewed October 2026 for 2027 planning. Medical statements were checked against current American Heart Association, American College of Cardiology, and NIH heart-failure resources. Underwriting guidance uses PinnacleQuote’s Universal CHF screening framework as a starting point before carrier-specific review.
